Agilus Diagnostics and Sebia launch anti-MCV test in India for early rheumatoid arthritis detection

The anti-MCV test enables early identification of rheumatoid arthritis in patients who test negative for standard markers like anti-CCP and RF
The post Agilus Diagnostics and Sebia launch anti-MCV test in India for early rheumatoid arthritis detection appeared first on Express Healthcare.